8/8/2013 7:51:08 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
AVEO Oncology (NASDAQ: AVEO) today reported second quarter 2013 financial results.
“We are moving forward as an organization and are firmly focused on executing our revised business strategy,” said Tuan Ha-Ngoc, president and chief executive officer of AVEO. “We continue to advance our programs in clinical development, including tivozanib in colorectal and breast cancer, which are currently in Phase 2 studies.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by